These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30932257)
1. Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer. Qin Y; Hu Q; Ji S; Xu J; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Yu X; Zhang B; Xu X Cell Prolif; 2019 May; 52(3):e12603. PubMed ID: 30932257 [TBL] [Abstract][Full Text] [Related]
2. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis. Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. Zhai S; Xu Z; Xie J; Zhang J; Wang X; Peng C; Li H; Chen H; Shen B; Deng X Oncogene; 2021 Jan; 40(2):277-291. PubMed ID: 33122827 [TBL] [Abstract][Full Text] [Related]
4. Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis. Hashimoto K; Tsuji Y J Mol Biol; 2017 Jan; 429(1):64-78. PubMed ID: 27884605 [TBL] [Abstract][Full Text] [Related]
5. TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer. Xiang J; Hu Q; Qin Y; Ji S; Xu W; Liu W; Shi S; Liang C; Liu J; Meng Q; Liang D; Ni Q; Xu J; Zhang B; Yu X Cell Death Dis; 2018 Feb; 9(3):321. PubMed ID: 29476053 [TBL] [Abstract][Full Text] [Related]
6. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585 [TBL] [Abstract][Full Text] [Related]
7. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Isono K; Nemoto K; Li Y; Takada Y; Suzuki R; Katsuki M; Nakagawara A; Koseki H Mol Cell Biol; 2006 Apr; 26(7):2758-71. PubMed ID: 16537918 [TBL] [Abstract][Full Text] [Related]
8. Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Wang H; Wang J; Liu J; Wang Y; Xia G; Huang X Cell Signal; 2022 May; 93():110282. PubMed ID: 35176452 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling. Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041 [TBL] [Abstract][Full Text] [Related]
10. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. He TL; Zhang YJ; Jiang H; Li XH; Zhu H; Zheng KL Med Oncol; 2015 Jul; 32(7):187. PubMed ID: 26021472 [TBL] [Abstract][Full Text] [Related]
11. Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy. Garufi A; Ricci A; Trisciuoglio D; Iorio E; Carpinelli G; Pistritto G; Cirone M; D'Orazi G Cell Death Dis; 2013 May; 4(5):e639. PubMed ID: 23703384 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of HIPK2 attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ Biomed Pharmacother; 2017 Jan; 85():575-581. PubMed ID: 27890429 [TBL] [Abstract][Full Text] [Related]
13. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569 [TBL] [Abstract][Full Text] [Related]
14. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation. Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497 [TBL] [Abstract][Full Text] [Related]
15. CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer. Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z Biochem Biophys Res Commun; 2018 Jun; 500(3):691-697. PubMed ID: 29678579 [TBL] [Abstract][Full Text] [Related]
16. The nutrient sensor OGT regulates Hipk stability and tumorigenic-like activities in Wong KKL; Liu TW; Parker JM; Sinclair DAR; Chen YY; Khoo KH; Vocadlo DJ; Verheyen EM Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2004-2013. PubMed ID: 31932432 [TBL] [Abstract][Full Text] [Related]
17. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells. D'Orazi G; Sciulli MG; Di Stefano V; Riccioni S; Frattini M; Falcioni R; Bertario L; Sacchi A; Patrignani P Clin Cancer Res; 2006 Feb; 12(3 Pt 1):735-41. PubMed ID: 16467083 [TBL] [Abstract][Full Text] [Related]
18. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression. Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674 [TBL] [Abstract][Full Text] [Related]
19. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma. Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136 [TBL] [Abstract][Full Text] [Related]
20. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]